A detailed history of Oberweis Asset Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Oberweis Asset Management Inc holds 177,795 shares of HAE stock, worth $12.3 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
177,795
Previous 165,295 7.56%
Holding current value
$12.3 Million
Previous $13.7 Million 4.5%
% of portfolio
0.77%
Previous 0.87%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $905,625 - $1.14 Million
12,500 Added 7.56%
177,795 $14.3 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $1.75 Million - $2.1 Million
21,600 Added 15.03%
165,295 $13.7 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $2.69 Million - $3.23 Million
37,815 Added 35.71%
143,695 $12.3 Million
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $2.3 Million - $2.64 Million
28,480 Added 36.8%
105,880 $9.05 Million
Q3 2023

Nov 14, 2023

BUY
$82.56 - $93.49 $2.47 Million - $2.8 Million
29,900 Added 62.95%
77,400 $6.93 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $856,904 - $948,170
10,600 Added 28.73%
47,500 $4.04 Million
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $1.25 Million - $1.56 Million
17,200 Added 87.31%
36,900 $3.05 Million
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $1.45 Million - $1.7 Million
19,700 New
19,700 $1.55 Million
Q1 2019

May 15, 2019

SELL
$83.25 - $102.12 $3.37 Million - $4.14 Million
-40,535 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$90.66 - $116.63 $1.12 Million - $1.44 Million
-12,365 Reduced 23.37%
40,535 $4.06 Million
Q3 2018

Nov 14, 2018

BUY
$89.96 - $114.58 $1.66 Million - $2.12 Million
18,480 Added 53.69%
52,900 $6.06 Million
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $2.46 Million - $3.3 Million
34,420 New
34,420 $3.09 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.